P3 Health Partners (PIII) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
30 Mar, 2026Market opportunity and industry trends
Operates in a $1.2T Medicare Advantage and FFS Medicare market, with 54% MA penetration in 2025 and growing senior care demand.
Value-based care is driving a $4T+ reduction in projected Medicare spending, emphasizing cost control and quality outcomes.
Macro tailwinds include industry consolidation, payor cost pressure, and expanding addressable market.
Business model and solutions
Physician-led, enabling providers to transition from fee-for-service to value-based care, improving outcomes and lowering costs.
Assumes full financial risk for patients, aligning incentives for prevention and wellness.
Integrated care model leverages data, technology, and community outreach for scalable, capital-efficient operations.
Delivers measurable cost savings, enhanced quality, and high physician retention through partnerships and network solutions.
Operational performance and growth
Manages 140K total lives, with ~115K at-risk and ~30K under management across four states, expanding into Nebraska in 2026.
Holds significant market share in Arizona (22%), Nevada (9%), and Oregon (28%), focusing on high-impact counties.
Four operational pillars: patient outcomes, tech-enabled efficiency, provider well-being, and scalable value creation.
Pathway to profitability driven by contract restructuring, operational execution, and payer mix optimization.
Latest events from P3 Health Partners
- 2026 outlook projects a $170M EBITDA improvement and 29,000 new Medicare Advantage members.PIII
Q4 202526 Mar 2026 - Operational focus and technology upgrades target margin growth and cash flow positivity by 2025.PIII
17th Annual LD Micro Main Event Conference13 Feb 2026 - Q2 revenue up 15% to $379M, but profitability declined and liquidity risks remain.PIII
Q2 20242 Feb 2026 - Membership and revenue surge, tech innovation, and efficiency drive future growth.PIII
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Tech-enabled value-based care and disciplined growth drive profitability and expansion.PIII
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Revenue up 26% year-over-year, but net loss widened and liquidity risks persist.PIII
Q3 202414 Jan 2026 - $130M+ turnaround and value-based care drive 2025 profitability and growth.PIII
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - 2024 revenue up 18% to $1.5B; 2025 guidance targets profitability despite wider net loss.PIII
Q4 202426 Dec 2025 - Registering 134.8M shares for resale, with proceeds from warrants to fund growth amid ongoing losses.PIII
Registration Filing16 Dec 2025